-
Nanotechnology, Science and Applications
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biosensors: the new wave in cancer diagnosis
Review
(5372) Views (4602) Full article downloads
Authors: Brian Bohunicky, Shaker A Mousa
Published Date December 2010
Volume 2011:4 Pages 1 - 10
DOI: http://dx.doi.org/10.2147/NSA.S13465
Brian Bohunicky1, Shaker A Mousa1,21The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA; 2College of Medicine, King Saud University, Riyadh, Saudi Arabia
Abstract: The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers are diagnosed only after they have metastasized throughout the body. Effective, accurate methods of cancer detection and clinical diagnosis are urgently needed. Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents. This review will briefly summarize the current obstacles to early detection of cancer and the expanding use of biosensors as a diagnostic tool, as well as some future applications of biosensor technology.
Keywords: biosensor, oncogene, nanotechnology, biotechnology, cancer detection, diagnosis, point-of-care
Other articles by Professor Shaker Mousa
Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
Pharmacogenomics in osteoporosis: Steps toward personalized medicine
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
Prevention strategies for antimicrobial resistance: a systematic review of the literature
The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent
Readers of this article also read:
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
Nanoparticles as biochemical sensors
Emerging use of nanostructure films containing capped gold nanoparticles in biosensors
The design, fabrication, and photocatalytic utility of nanostructured semiconductors: focus on TiO2-based nanostructures
The current state of engineered nanomaterials in consumer goods and waste streams: the need to develop nanoproperty-quantifiable sensors for monitoring engineered nanomaterials
Biocompatible medical implant materials with binding sites for a biodegradable drug-delivery system
Superhydrophobic nature of nanostructures on an indigenous Australian eucalyptus plant and its potential application
Transforming nanostructured chitin from crustacean waste into beneficial health products: a must for our society
Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Applications of gold nanoparticles in cancer nanotechnology
- Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer
- Gold nanoparticles: From nanomedicine to nanosensing
- Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases




